Prevalence and determinants of the place of delivery among reproductive age women in sub-Saharan Africa.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 24 06 2020
accepted: 17 12 2020
entrez: 31 12 2020
pubmed: 1 1 2021
medline: 23 3 2021
Statut: epublish

Résumé

Maternal mortality is an issue of global public health concern with over 300,000 women dying globally each year. In sub-Saharan Africa (SSA), these deaths mainly occur around childbirth and the first 24hours after delivery. The place of delivery is, therefore, important in reducing maternal deaths and accelerating progress towards attaining the 2030 sustainable development goals (SDGs) related to maternal health. In this study, we examined the prevalence and determinants of the place of delivery among reproductive age women in SSA. This was a cross-sectional study among women in their reproductive age using data from the most recent demographic and health surveys of 28 SSA countries. Frequency, percentage, chi-square, and logistic regression were used in analysing the data. All analyses were done using STATA. The overall prevalence of health facility delivery was 66%. This ranged from 23% in Chad to 94% in Gabon. More than half of the countries recorded a less than 70% prevalence of health facility delivery. The adjusted odds of health facility delivery were lowest in Chad. The probability of giving birth at a health facility also declined with increasing age but increased with the level of education and wealth status. Women from rural areas had a lower likelihood (AOR = 0.59, 95%CI = 0.57-0.61) of delivering at a health facility compared with urban women. Our findings point to the inability of many SSA countries to meet the SDG targets concerning reductions in maternal mortality and improving the health of reproductive age women. The findings thus justify the need for peer learning among SSA countries for the adaption and integration into local contexts, of interventions that have proven to be successful in improving health facility delivery among reproductive age women.

Identifiants

pubmed: 33382825
doi: 10.1371/journal.pone.0244875
pii: PONE-D-20-19469
pmc: PMC7774912
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0244875

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist

Références

BMC Public Health. 2019 Jul 10;19(1):924
pubmed: 31291919
Lancet. 2006 Oct 28;368(9546):1535-41
pubmed: 17071287
Pan Afr Med J. 2014 Dec 03;19:349
pubmed: 25922638
Int J Hypertens. 2018 Apr 26;2018:8307591
pubmed: 29854433
PLoS One. 2019 Jan 9;14(1):e0209985
pubmed: 30625212
BMC Pregnancy Childbirth. 2012 Jul 10;12:66
pubmed: 22780957
BMC Public Health. 2019 May 21;19(1):616
pubmed: 31113395
Health Econ Rev. 2016 Dec;6(1):24
pubmed: 27325249
Reprod Health. 2017 Sep 6;14(1):112
pubmed: 28877749
BMC Res Notes. 2017 Jul 11;10(1):268
pubmed: 28693617
J Health Popul Nutr. 2018 Oct 22;37(1):22
pubmed: 30348219
Reprod Health. 2016 Jun 17;13(1):77
pubmed: 27316970
BMC Public Health. 2014 Sep 28;14:1014
pubmed: 25263746
PLoS One. 2018 Aug 6;13(8):e0201833
pubmed: 30080875
Int J Reprod Med. 2016;2016:6569514
pubmed: 28116348
Reprod Health. 2014 Mar 15;11:23
pubmed: 24628727
Semin Perinatol. 2019 Aug;43(5):252-259
pubmed: 31104765
BMC Womens Health. 2020 Feb 11;20(1):25
pubmed: 32046703
Sci Data. 2019 Jul 25;6(1):134
pubmed: 31346183
BMJ Glob Health. 2020 Jan 26;5(1):e002231
pubmed: 32133182
BMC Public Health. 2020 Feb 3;20(1):164
pubmed: 32013896
BMC Health Serv Res. 2016 Jul 12;16:252
pubmed: 27405375
Int Health. 2018 Jan 1;10(1):1-3
pubmed: 29325056
BMC Pregnancy Childbirth. 2019 Oct 21;19(1):366
pubmed: 31638927
BMC Pregnancy Childbirth. 2015 Nov 13;15:297
pubmed: 26566812
Bull World Health Organ. 2013 May 1;91(5):318-9
pubmed: 23678193
Int J Reprod Med. 2016;2016:7203980
pubmed: 28101522
Reprod Health. 2019 Jun 25;16(1):89
pubmed: 31238960
PLoS One. 2017 Jan 3;12(1):e0169304
pubmed: 28046036
Int J Reprod Med. 2019 Jul 1;2019:2852861
pubmed: 31355245
PLoS One. 2018 Jan 16;13(1):e0190145
pubmed: 29337995
BJOG. 2009 Oct;116 Suppl 1:33-40
pubmed: 19740170
Glob Health Action. 2014 Aug 11;7:24580
pubmed: 25119066
Reprod Health. 2019 Jul 10;16(1):101
pubmed: 31291958
BMC Public Health. 2018 Jun 19;18(1):765
pubmed: 29921275

Auteurs

Kenneth Setorwu Adde (KS)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.

Kwamena Sekyi Dickson (KS)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.

Hubert Amu (H)

Department of Population and Behavioural Sciences, School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH